Latest / Texas News Today | 2 Min News | The Daily News Now!
FDA Approves First Alzheimer’s Drug in Years | Texas News
FDA just approved Leqembi, the first drug in decades to target Alzheimer’s root cause—amyloid plaques—slowing cognitive decline in early-stage patients. It’s not a cure, but it offers real hope for preserving memory and independence longer. The catch? Intravenous infusions every two weeks, pricey costs, and serious side effects like brain swelling requiring MRI monitoring. This breakthrough marks a pivotal shift toward treating Alzheimer’s at its source, though access and affordability remain huge hurdles. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.